SCHEMBL17295630

SCHEMBL17295630

CCCCN1C(=O)C(=Cc2ccc3[nH]ccc3c2)SC1=NCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.52
▸ MAPT P10636 4/20 0.52
▸ HPGD P15428 2/20 0.52
▸ NPSR1 Q6W5P4 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ LMNA P02545 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ S1PR1 P21453 6/20 0.44
▸ S1PR3 Q99500 6/20 0.44
▸ FAAH O00519 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ENPP2 Q13822 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ ACP1 P24666 1/20 0.39
▸ CFTR P13569 1/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295628 1.00 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295415 0.92 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295414 0.92 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL29726504 0.90 MAPT (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295269 0.90 MAPT (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295268 0.90 MAPT (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17302191 0.87 FAAH (0.57) MAPTHPGDNPSR1MEN1KMT2A
SCHEMBL17295444 0.84 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295448 0.84 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL19096352 0.84 ALDH1A1 (0.59) ALDH1A1MAPTHPGDNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback